Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2651 |
|
| Actual shortage: | 257 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2385 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-09-30 | 2021-10-21 | 146462 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-21 | 2021-11-11 | 147711 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-11-11 | 2022-01-07 | 149105 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-20 | 2022-03-09 | 153177 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Actual shortage | 2022-01-27 | 2022-09-22 | 153721 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154726 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Actual shortage | 2022-02-17 | 2022-09-22 | 155171 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-24 | 2022-05-05 | 157265 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-03-24 | 2022-04-09 | 157271 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-06-03 | 2022-08-16 | 161958 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-06-03 | 2022-08-16 | 161961 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161964 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-06-30 | 2023-04-28 | 163945 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-06-30 | 2022-10-18 | 163954 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-02-22 | 166972 |
| TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-08-18 | 2022-10-29 | 167226 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-08 | 170779 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170784 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |